http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102274420-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-59 |
filingDate | 2015-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102274420-B1 |
titleOfInvention | Pharmaceutical composition with improved stability |
abstract | The present invention provides an injectable composition for sustained-release drug delivery and a method for preparing the same, wherein the composition has a weight average molecular weight between 5,000 and 50,000 Daltons, an acid value of less than 3 mgKOH/g, and a lactate-based polymer of less than about 0.3% by weight. a lactate-based polymer having a content of residual lactide monomer in it; pharmaceutically acceptable organic solvents; and a physiologically active substance or a salt thereof containing the amino acid serine in its molecular structure capable of reacting with a lactide monomer to form a conjugate; The composition reduces the formation of conjugates. |
priorityDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 870.